V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270012916 | 270016672 | 1.92 | null | Curative (C) | 2015-09-29 | 2015-10-03 | Escalated BEACOPP | N | Y | 270012861 | BEACOPP |
| 270012919 | 270008475 | 1.86 | 80 | Curative (C) | 2014-01-24 | 2014-03-19 | BEACOPP-14 | N | null | 270012874 | BEACOPP |
| 270012920 | 270014007 | null | 29 | Palliative (P) | 2016-11-24 | 2017-01-05 | Cetuximab 7 day (>Cycle 2) | N | null | 270012875 | CETUXIMAB |
| 270012921 | 270008476 | null | 85 | Palliative (P) | 2016-04-05 | 2016-04-24 | Cetuximab 14 day | N | N | 270012881 | CETUXIMAB |
| 270012922 | 270008477 | null | 98.2 | null | 2015-02-12 | 2015-02-14 | CETUXIMAB | N | N | 270012882 | CETUXIMAB |
| 270012923 | 270008479 | 0 | 28.8 | Curative (C) | 2015-05-13 | 2015-05-15 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012895 | TRIAL |
| 270012924 | 270008480 | 1.85 | 53.8 | Curative (C) | 2016-06-25 | 2016-07-08 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012896 | TRIAL |
| 270012925 | 270008480 | 0 | 61.2 | Curative (C) | 2016-12-05 | 2017-02-12 | COPP + Dacarbazine | 02 | N | 270012896 | COPP + DACARBAZINE |
| 270012926 | 270014010 | null | 50.75 | Curative (C) | 2013-04-26 | 2013-05-19 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012901 | TRIAL |
| 270012927 | 270014010 | null | 100.8 | Curative (C) | 2014-10-10 | 2014-10-24 | HD EuroNet-PHL-C1 COPDAC | 1 | N | 270012901 | TRIAL |
| 270012928 | 270018209 | 1.72 | 78 | Curative (C) | 2015-09-11 | 2015-09-17 | CETUXIMAB | N | N | 270012903 | CETUXIMAB |
| 270012929 | 270018209 | null | 66.7 | Palliative (P) | 2017-04-26 | 2017-05-13 | CETUXIMAB | N | N | 270012903 | CETUXIMAB |
| 270012930 | 270014011 | 1.64 | 38.4 | Curative (C) | 2015-05-26 | 2015-07-20 | Trial Unspecified | N | N | 270012907 | TRIAL |
| 270012931 | 270014011 | null | 81.4 | null | 2014-08-16 | 2014-11-08 | BEACOPP | N | N | 270012907 | BEACOPP |
| 270012932 | 270008485 | 1.77 | 99.4 | Palliative (P) | 2017-11-04 | 2017-11-26 | Cetuximab 7 day (>Cycle 2) | N | N | 270012908 | CETUXIMAB |
| 270012933 | 270008487 | 1.8 | 73.5 | Curative (C) | 2016-05-24 | 2016-06-04 | Escalated BEACOPP | null | N | 270012909 | BEACOPP |
| 270012934 | 270008487 | 0 | null | Curative (C) | null | 2015-10-04 | COPP + Dacarbazine | N | N | 270012909 | COPP + DACARBAZINE |
| 270012935 | 270008487 | 1.78 | null | Curative (C) | null | 2016-03-12 | Trial Unspecified | N | N | 270012909 | TRIAL |
| 270012936 | 270008487 | null | 62 | Curative (C) | 2015-07-22 | 2016-05-02 | Trial Unspecified | 1 | Y | 270012909 | TRIAL |
| 270012937 | 270008488 | 1.73 | 59.2 | Neo-adjuvant (N) | null | 2017-01-20 | BEACOPP | N | N | 270012920 | BEACOPP |
| 270012938 | 270016678 | 0 | 53.5 | Curative (C) | null | 2016-03-11 | HD EuroNet-PHL-C1 Relapsed IEP | Y | N | 270012925 | TRIAL |
| 270012939 | 270008490 | 1.68 | 53.2 | Curative (C) | 2016-06-11 | 2016-06-11 | COPP + Dacarbazine | N | N | 270012935 | COPP + DACARBAZINE |
| 270012940 | 270014015 | 0 | 29 | Curative (C) | 2014-09-15 | 2014-10-06 | COPP + Dacarbazine | N | N | 270012939 | COPP + DACARBAZINE |
| 270012945 | 270016680 | 0 | 79.1 | Curative (C) | 2015-01-08 | 2015-01-09 | HD EuroNet-PHL-C1 Relapsed IEP | N | N | 270012948 | TRIAL |
| 270012946 | 270008497 | null | 70.1 | Curative (C) | 2016-02-18 | 2016-02-18 | COPP + Dacarbazine | N | N | 270012949 | COPP + DACARBAZINE |
| 270012947 | 270008497 | null | 94.8 | Palliative (P) | 2014-08-31 | 2015-02-14 | CETUXIMAB | N | N | 270012949 | CETUXIMAB |
| 270012948 | 270008499 | 1.59 | 38.2 | Curative (C) | 2015-03-10 | 2015-03-14 | BEACOPP | N | null | 270012955 | BEACOPP |
| 270012949 | 270008500 | 1.86 | 45.2 | Curative (C) | 2014-12-21 | 2014-12-21 | COPP + Dacarbazine | N | null | 270012955 | COPP + DACARBAZINE |
| 270012950 | 270008501 | 1.81 | 56.3 | Curative (C) | 2014-03-02 | 2014-07-04 | Cetuximab 14 day | N | N | 270012961 | CETUXIMAB |
| 270012951 | 270016682 | null | 51 | Disease modification (D) | 2014-06-28 | 2014-06-30 | BEACOPP | N | N | 270012966 | BEACOPP |
| 270012952 | 270016682 | 1.84 | 59.6 | Palliative (P) | 2017-12-01 | 2017-12-01 | CETUXIMAB | N | N | 270012966 | CETUXIMAB |
| 270012953 | 270008502 | 1.78 | 47.8 | Curative (C) | 2014-06-22 | 2014-10-13 | CETUXIMAB | N | null | 270012975 | CETUXIMAB |
| 270012954 | 270008505 | 1.76 | 101 | Neo-adjuvant (N) | 2015-11-10 | 2015-11-10 | COPP + Dacarbazine | N | N | 270012979 | COPP + DACARBAZINE |
| 270012955 | 270008506 | 0 | 49.9 | Curative (C) | 2017-02-04 | 2017-08-12 | Trial Unspecified | Y | null | 270012980 | TRIAL |
| 270012956 | 270008507 | 0 | null | Curative (C) | 2016-04-04 | 2016-04-07 | Trial Unspecified | N | N | 270012982 | TRIAL |
| 270012957 | 270014025 | 1.71 | 90 | Not known (9) | 2016-02-12 | 2016-02-19 | HD EuroNet-PHL-C1 COPDAC | N | null | 270012985 | TRIAL |
| 270012958 | 270014025 | 0 | 47.8 | Curative (C) | 2016-08-08 | 2016-08-10 | COPP + Dacarbazine | N | N | 270012985 | COPP + DACARBAZINE |
| 270012959 | 270014025 | 1.66 | 87 | Curative (C) | 2017-11-28 | 2017-11-28 | COPP + Dacarbazine | N | N | 270012985 | COPP + DACARBAZINE |
| 270012960 | 270008508 | 1.81 | 69.5 | Palliative (P) | 2013-06-05 | 2013-06-06 | HD EuroNet-PHL-C1 COPDAC | N | null | 270012994 | TRIAL |
| 270012961 | 270008509 | 1.8 | 99.4 | Curative (C) | null | 2017-06-16 | Cetuximab 7 day (Cycle 1) | N | N | 270012995 | CETUXIMAB |
| 270012962 | 270008509 | 1.69 | 35 | Palliative (P) | 2013-12-19 | 2014-02-17 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012995 | TRIAL |
| 270012963 | 270008509 | 0 | 62.9 | Curative (C) | null | 2013-11-12 | COPP + Dacarbazine | 02 | N | 270012995 | COPP + DACARBAZINE |
| 270012964 | 270008509 | 0 | 28.9 | Adjuvant (A) | 2014-11-27 | 2014-11-28 | COPP + Dacarbazine | N | null | 270012995 | COPP + DACARBAZINE |
| 270012965 | 270008509 | 1.77 | 56.2 | Palliative (P) | 2018-02-06 | 2018-02-15 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012995 | TRIAL |
| 270012966 | 270008510 | 1.78 | 94.7 | Curative (C) | 2016-04-22 | 2016-07-22 | BEACOPP-14 | N | N | 270013005 | BEACOPP |
| 270012967 | 270008510 | 1.57 | 72 | Curative (C) | 2014-10-23 | 2014-11-09 | CETUXIMAB | N | N | 270013005 | CETUXIMAB |
| 270012968 | 270008510 | 0 | 75 | Curative (C) | 2015-05-31 | 2015-07-25 | COPP + Dacarbazine | N | N | 270013005 | COPP + DACARBAZINE |
| 270012969 | 270008510 | 0 | 49.3 | Curative (C) | 2013-11-11 | 2014-01-08 | COPP + Dacarbazine | N | N | 270013005 | COPP + DACARBAZINE |
| 270012970 | 270008510 | null | 101.2 | Curative (C) | 2014-09-12 | 2014-10-06 | Escalated BEACOPP | 2 | N | 270013005 | BEACOPP |
| 270012971 | 270008511 | null | 69.5 | Curative (C) | 2015-08-21 | 2015-08-31 | BEACOPP | N | null | 270013017 | BEACOPP |